134 related articles for article (PubMed ID: 37574050)
21. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
22. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since?
Cockerell CJ; Berson DS
Am J Dermatopathol; 1985; 7 Suppl():93-7. PubMed ID: 3940095
[TBL] [Abstract][Full Text] [Related]
23. Small congenital nevi associated with melanoma: case reports and considerations.
Betti R; Inselvini E; Vergani R; Crosti C
J Dermatol; 2000 Sep; 27(9):583-90. PubMed ID: 11052234
[TBL] [Abstract][Full Text] [Related]
24. Nevus-associated melanomas: clinicopathologic features.
Shitara D; Nascimento MM; Puig S; Yamada S; Enokihara MM; Michalany N; Bagatin E
Am J Clin Pathol; 2014 Oct; 142(4):485-91. PubMed ID: 25239415
[TBL] [Abstract][Full Text] [Related]
25. Melanoma in association with acquired melanocytic nevus in Japan: a review of cases in the literature.
Togawa Y; Nakamura Y; Kamada N; Kambe N; Takahashi Y; Matsue H
Int J Dermatol; 2010 Dec; 49(12):1362-7. PubMed ID: 21155082
[TBL] [Abstract][Full Text] [Related]
26. Malignant Melanoma in Association With a Thymic Nevus in a Patient With a Giant Congenital Nevus.
Shvartser-Beryozkin Y; Yakobson A; Benharroch D; Saute M; Feinmesser M
Am J Dermatopathol; 2017 Jul; 39(7):538-541. PubMed ID: 28033154
[TBL] [Abstract][Full Text] [Related]
27. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
Googe PB; Flanigan KL; Miedema JR
Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
[TBL] [Abstract][Full Text] [Related]
28. Black lesions of the skin.
BECKER SW
Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
[TBL] [Abstract][Full Text] [Related]
29. Nevus, melanoma, or something else? Mesenchymal neoplasms with melanocytic differentiation.
Evangelou Z; Linos K
J Cutan Pathol; 2022 Aug; 49(8):747-759. PubMed ID: 35338512
[TBL] [Abstract][Full Text] [Related]
30. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression.
King R; Hayzen BA; Page RN; Googe PB; Zeagler D; Mihm MC
Mod Pathol; 2009 May; 22(5):611-7. PubMed ID: 19270643
[TBL] [Abstract][Full Text] [Related]
31. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
Santucci M; Urso C; Giannini A; Bondi R
Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
[TBL] [Abstract][Full Text] [Related]
32. FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
J Cutan Pathol; 2023 Mar; 50(3):247-258. PubMed ID: 36454046
[TBL] [Abstract][Full Text] [Related]
33. Proliferative activity of primary cutaneous melanocytic tumours.
Kuwata T; Kitagawa M; Kasuga T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
[TBL] [Abstract][Full Text] [Related]
34. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
35. Changes in melanocytic nevi treated with laser hair removal: A systematic review.
Cices A; Dover JS; Labadie JG
Lasers Surg Med; 2023 Sep; 55(7):617-624. PubMed ID: 37493510
[TBL] [Abstract][Full Text] [Related]
36. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
37. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
38. Increased epidermal growth factor receptors in melanocytic lesions.
Ellis DL; King LE; Nanney LB
J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
Bröcker EB; Magiera H; Herlyn M
J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
[TBL] [Abstract][Full Text] [Related]
40. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
